Glucagon Receptor Agonists [MoA] - N0000193923
Pharmacologic Class Information
Pharmacologic Code | N0000193923 |
Pharmacologic Name | Glucagon Receptor Agonists |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Glucagon Receptor Agonists
The table contains 4 products whose active ingredient are classified under the same pharmacologic class Glucagon Receptor Agonists [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0169-1912 | Zegalogue | Non-Proprietary Name: Dasiglucagon | Injection, Solution | Subcutaneous | Novo Nordisk | ACTIVE | |
0169-1913 | Zegalogue | Non-Proprietary Name: Dasiglucagon | Injection, Solution | Subcutaneous | Novo Nordisk | ACTIVE | |
80644-0012 | Zegalogue | Non-Proprietary Name: Dasiglucagon | Injection, Solution | Subcutaneous | Zealand Pharma Us, Inc | ACTIVE | |
80644-0013 | Zegalogue | Non-Proprietary Name: Dasiglucagon | Injection, Solution | Subcutaneous | Zealand Pharma Us, Inc | ACTIVE |